Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma.
Saved in:
| Title: | Romidepsin and Afatinib Abrogate Jak-Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma. |
|---|---|
| Authors: | Shih BB; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Ma C; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Cortes JR; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Regeneron Pharmaceuticals, Tarrytown, New York, USA., Reglero C; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Miller H; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Quinn SA; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Albero R; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Biomedical Research Institute August Pi y Sunyer (IDIBAPS), Barcelona, Spain., Laurent AP; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Mackey A; Institute for Cancer Genetics, Columbia University, New York, New York, USA., Ferrando AA; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Regeneron Pharmaceuticals, Tarrytown, New York, USA; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA; Department of Pediatrics, Columbia University Medical Center, New York, New York, USA; Department of Systems Biology, Columbia University Medical Center, New York, New York, USA., Geskin L; Department of Medicine, Columbia University Medical Center, New York, New York, USA., Palomero T; Institute for Cancer Genetics, Columbia University, New York, New York, USA; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA. Electronic address: tp2151@cumc.columbia.edu. |
| Source: | The Journal of investigative dermatology [J Invest Dermatol] 2024 Jul; Vol. 144 (7), pp. 1579-1589.e8. Date of Electronic Publication: 2024 Jan 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
